Skip to main content
. 2021 Sep 12;2021(9):CD011612. doi: 10.1002/14651858.CD011612.pub3

28.2. Analysis.

28.2

Comparison 28: Ketamine versus Placebo (pre‐planned sensitivity analysis: excluding studies that included participants with bipolar disorder or psychotic features), Outcome 2: Remission rate